Groesbeck Investment Management Corp NJ purchased a new stake in shares of Genpact Limited (NYSE:G – Free Report) during the fourth quarter, Holdings Channel reports. The fund purchased 4,938 shares of the business services provider’s stock, valued at approximately $212,000.
Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. boosted its stake in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after purchasing an additional 433 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in shares of Genpact by 74.6% during the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock valued at $103,000 after purchasing an additional 1,121 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Genpact by 221.3% during the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock valued at $131,000 after purchasing an additional 2,293 shares in the last quarter. Versant Capital Management Inc lifted its stake in shares of Genpact by 17.0% in the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock worth $136,000 after acquiring an additional 461 shares during the period. Finally, MassMutual Private Wealth & Trust FSB lifted its stake in shares of Genpact by 22.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider’s stock worth $145,000 after acquiring an additional 619 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Trading Up 0.9 %
NYSE G opened at $49.37 on Wednesday. The company has a market cap of $8.71 billion, a price-to-earnings ratio of 13.56, a P/E/G ratio of 1.61 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $49.47. The business has a 50 day moving average price of $44.80 and a 200-day moving average price of $41.04.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on G shares. TD Cowen lifted their target price on Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a report on Friday, November 8th. Needham & Company LLC lifted their target price on Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, November 11th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Robert W. Baird lifted their target price on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $44.50.
View Our Latest Research Report on G
Insiders Place Their Bets
In other news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares in the company, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,058 shares of company stock valued at $1,558,675. Insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Why Invest in 5G? How to Invest in 5G Stocks
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- ETF Screener: Uses and Step-by-Step Guide
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- How to buy stock: A step-by-step guide for beginners
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.